But this transformation may be nothing compared to the impact of the next generation of weight-loss drugs, which will be available in tablet form, with early results suggesting it will be even more ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...
Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...
Chief executive turnover surged in August and is now at the highest level year-to-date on record, according to data from coaching firm Challenger, Gray & Christmas.